MedPath

Prednicarbate

Generic Name
Prednicarbate
Brand Names
Dermatop
Drug Type
Small Molecule
Chemical Formula
C27H36O8
CAS Number
73771-04-7
Unique Ingredient Identifier
V901LV1K7D

Overview

Prednicarbate is a relatively new topical corticosteroid drug that displays a similar potency as hydrocortisone. It is used in the treatment of inflammatory skin diseases, such as atopic dermatitis. It has a favorable benefit-risk ratio, with an inflammatory action similar to that of a medium potency corticosteroid, but with a low potential to cause skin atrophy. The anti-inflammation action of corticosteroids is associated with the inhibition of the interleukin 1-alpha cytokine within keratinocytes. IL-1a is also found in fibroblasts, where it is responsible for proliferation, collagenase induction and IL-6 synthesis, which are related to skin thickness.

Background

Prednicarbate is a relatively new topical corticosteroid drug that displays a similar potency as hydrocortisone. It is used in the treatment of inflammatory skin diseases, such as atopic dermatitis. It has a favorable benefit-risk ratio, with an inflammatory action similar to that of a medium potency corticosteroid, but with a low potential to cause skin atrophy. The anti-inflammation action of corticosteroids is associated with the inhibition of the interleukin 1-alpha cytokine within keratinocytes. IL-1a is also found in fibroblasts, where it is responsible for proliferation, collagenase induction and IL-6 synthesis, which are related to skin thickness.

Indication

常用于各种炎性皮肤病的局部治疗。

Associated Conditions

  • Dermatosis

FDA Approved Products

Prednicarbate
Manufacturer:Fougera Pharmaceuticals Inc.
Route:TOPICAL
Strength:1.0 mg in 1 g
Approved: 2021/12/31
NDC:0168-0410

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath